Pharmaceutical Executive
August 01, 2007
News Analysis
0
0
Novartis' Zelnorm is back, but only through a restricted-access program.
August 01, 2007
News Analysis
0
0
A new study says obesity is like a social virus, so why is the obesity-drug market just sitting there?